Can a Healthy 45-Year-Old Woman Start Depo-Provera for Contraception?
Yes, a healthy 45-year-old woman can start Depo-Provera for contraception, but she should be counseled that use should not exceed 2 years due to bone mineral density concerns, and she must understand the critical bone health risks that are particularly relevant as she approaches menopause. 1
Key Considerations for This Age Group
Bone Mineral Density - The Primary Concern
The FDA label explicitly states a critical limitation: Depo-Provera should not be used for more than 2 years unless other birth control methods cannot be used 1. This is especially important for a 45-year-old woman who is approaching menopause, when bone loss naturally accelerates.
- Depo-Provera causes progressive loss of bone mineral density (BMD) that worsens with duration of use
- The longer the use, the greater the calcium loss from bones
- Bones may not fully recover after discontinuation, particularly concerning for someone nearing menopause 1
- Prolonged use increases risk of osteoporosis and fractures, especially after menopause 1
Meningioma Risk - New Critical Data
Most recent evidence from 2025 shows depot medroxyprogesterone acetate carries a relative risk of 2.43 for meningioma diagnosis, particularly in women starting at ages older than 31 years or with exposure longer than 4 years 2. This is directly relevant to your 45-year-old patient. While the number needed to harm is 1152 (suggesting low absolute risk), this represents a significant relative risk increase that must be disclosed 2.
Practical Initiation Guidelines
According to the 2024 CDC guidelines 3:
- Can start anytime if reasonably certain she's not pregnant
- If started >7 days after menses began, use backup contraception (barrier methods) for 7 days
- No examination required before initiation - only blood pressure measurement is needed for combined hormonal contraceptives, not for DMPA 3
Counseling Points That Must Be Addressed
What She Needs to Know:
Menstrual changes are expected: Irregular bleeding initially, progressing to amenorrhea in most users 1
Bone health monitoring: Given her age and proximity to menopause, consider baseline BMD assessment if planning use beyond 1-2 years
Breast cancer risk: Counsel about possible increased risk, though evidence remains mixed 1
Delayed return to fertility: May experience delay in ovulation/fertility after discontinuation, though less relevant at age 45 1
Does not protect against STIs: Additional barrier methods needed if STI risk exists 1
Meningioma risk: Particularly relevant given her age >31 years and if considering prolonged use 2
Alternative Considerations
Given the 2-year limitation and her age, consider discussing:
- IUDs (copper or levonorgestrel): No BMD concerns, effective through menopause
- Progestin-only pills: No BMD concerns, can use until menopause
- Implant: Effective for 3 years, no significant BMD loss
- The 2024 guidelines show all these methods can be initiated anytime with appropriate backup contraception timing 3
Common Pitfall to Avoid
Do not assume she has many reproductive years remaining and casually prescribe Depo-Provera without the 2-year discussion. At 45, she may be 5-10 years from menopause, and cumulative bone loss during this critical period could have lasting consequences. The FDA boxed warning exists specifically because of concerns about bone health in the perimenopausal transition 1.
Clinical Algorithm
- Confirm she is healthy with no contraindications (check blood pressure, screen for cardiovascular risk factors)
- Explicitly discuss the 2-year maximum duration recommendation and bone health implications
- Counsel about meningioma risk given her age >31 years
- If she accepts these limitations and still prefers Depo-Provera, initiate with appropriate backup contraception timing
- Plan to reassess at 2 years and transition to alternative method
- Consider baseline BMD if available and planning any extended use